8[8]Delayed emesis induced by moderatelyemetogenic chemotherapy: do we need to treat allpatients? The Italian Group for AntiemeticResearch[J]. Ann-oncol, 1997,8(6):561-567.
9[9]Lofters-WS, Pater-JL, Zee-B. Phase Ⅲ double-blind comparison of dolasetron mesylatic andondansetron and an evaluation of the additiverole of dexame thasone in the prevention ofacute and delayed nausea and vomiting due tomoderately emetogenic chemotherapy[J]. J-Clin-Oncol,1997,15(8):2966-2973.
